Table S7. Pattern of failure after SABR for primary lung cancer in selected literature.
| Study (year) | Total No. of failure | LF, n (%) | RF, n (%) | DF, n (%) | LF + RF, n (%) | LF + DF, n (%) | RF + DF, n (%) | LF + RF + DF, n (%) |
|---|---|---|---|---|---|---|---|---|
| Baumann 2006 (34) | 44 | 4 (9.0) | 3 (7.0) | 22 (50.0) | 2 (4.0) | 9 (20.0) | 3 (7.0) | 1 (2.0) |
| Guckenberger 2009 (6) | 18 | 1 (2.0) | 4 (10.0) | 11 (27.0) | 0 | 0 | 2 (5.0) | 0 |
| Bradely 2010 (35) | 21 | 3 (14.0) | 1 (5.0] | 10 (47.0) | 2 (10.0) | 1 (5.0) | 3 (14.0) | 1 (5.0) |
| Olsen 2011 (36) | 25 | 4 (16.0) | 7 (28.0) | 6 (24.0) | 3 (12.0) | 0 | 4 (16.0) | 1 (4.0) |
| Haasbeck 2011 (37) | 17 | 1 (6.0) | 0 | 10 (59.0) | 1 (6.0) | 1 (6.0) | 3 (17.0) | 1 (6.0) |
| Taremi 2012 (38) | 31 | 7 (22.0) | 6 (19.0) | 12 (39.0) | 1 (3.0) | 1 (3.0) | 3 (9.0) | 1 (3.0) |
| Lee 2013 (39) | 21 | 4 (19.0) | 1 (95.0) | 8 (38.0) | 1 (5.0) | 3 (14.0) | 3 (14.0) | 1 (5.0) |
| Presented study | 40 | 6 (15.0) | 6 (15.0) | 12 (30.0) | 1 (2.5) | 5 (12.5) | 5 (12.5) | 5 (12.5) |
| PLLs | 22 | 4 (18.0) | 3 (13.0) | 3 (13.0) | 1 (5.0) | 1 (5.0) | 5 (23.0) | 5 (23.0) |
| MLLs | 18 | 2 (11.0) | 3 (17.0) | 9 (50.0) | 0 | 4 (22.0) | 0 | 0 |
SABR, stereotactic ablative radiotherapy; LF, local failure; RF, regional failure; DF, distant failure; PLLs, primary lung lesions; MLLs, metastatic lung lesions.